학술논문

Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
Document Type
Journal
Source
ALIMENTARY PHARMACOLOGY & THERAPEUTICS; JUN 1 2003, 17 11, p1355-p1364, 10p.
Subject
Language
English
ISSN
02692813